Materno-fetal pharmacokinetics and fetal distribution of valproic acid in a pregnant rhesus monkey. 1980

R G Dickinson, and C H Lawyer, and S N Kaufman, and R K Lynn, and N Gerber, and M J Novy, and M J Cook

Chronic indwelling catheters in the maternal femoral artery and vein, fetal carotid artery and jugular vein, and amniotic cavity of a pregnant rhesus monkey permitted administration of sodium valproate (NaVPA) and collection of timed samples of maternal and fetal blood and amniotic fluid. After a single IV dose (50 mg/kg) to the mother, a rapid distribution phase (t1/2 alpha = 0.5 minute) was followed by a biphasic decline in concentration in maternal blood (t1/2 beta = 31 minutes, t1/2 gamma = 390 minutes). VPA appeared rapidly in fetal blood, reached a concentration slightly higher than in maternal blood by 15 minutes, and thereafter declined in parallel with the concentration in maternal blood. Terminal fetal/maternal ratios of blood concentration of VPA were about 1.3. Similar patterns of decline were observed after NaVPA was given IV to the fetus. A multicompartment first-order materno-fetal pharmacokinetic model is presented. Tissue distribution studies in the fetus showed that VPA concentration was highest in blood; moderate in heart, liver, spleen, kidney, and skeletal muscle; and low in brain.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D005260 Female Females
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal
D000653 Amniotic Fluid A clear, yellowish liquid that envelopes the FETUS inside the sac of AMNION. In the first trimester, it is likely a transudate of maternal or fetal plasma. In the second trimester, amniotic fluid derives primarily from fetal lung and kidney. Cells or substances in this fluid can be removed for prenatal diagnostic tests (AMNIOCENTESIS). Amniotic Fluid Index,Amniotic Fluid Indices,Amniotic Fluids,Fluid Index, Amniotic,Fluid Indices, Amniotic,Fluid, Amniotic,Fluids, Amniotic,Index, Amniotic Fluid,Indices, Amniotic Fluid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

R G Dickinson, and C H Lawyer, and S N Kaufman, and R K Lynn, and N Gerber, and M J Novy, and M J Cook
January 1979, Proceedings of the Western Pharmacology Society,
R G Dickinson, and C H Lawyer, and S N Kaufman, and R K Lynn, and N Gerber, and M J Novy, and M J Cook
October 1988, Teratology,
R G Dickinson, and C H Lawyer, and S N Kaufman, and R K Lynn, and N Gerber, and M J Novy, and M J Cook
February 1981, Epilepsia,
R G Dickinson, and C H Lawyer, and S N Kaufman, and R K Lynn, and N Gerber, and M J Novy, and M J Cook
June 1984, Epilepsia,
R G Dickinson, and C H Lawyer, and S N Kaufman, and R K Lynn, and N Gerber, and M J Novy, and M J Cook
January 1986, Drug metabolism and disposition: the biological fate of chemicals,
R G Dickinson, and C H Lawyer, and S N Kaufman, and R K Lynn, and N Gerber, and M J Novy, and M J Cook
December 1995, Drug metabolism and disposition: the biological fate of chemicals,
R G Dickinson, and C H Lawyer, and S N Kaufman, and R K Lynn, and N Gerber, and M J Novy, and M J Cook
October 1984, Epilepsia,
R G Dickinson, and C H Lawyer, and S N Kaufman, and R K Lynn, and N Gerber, and M J Novy, and M J Cook
May 1974, American journal of obstetrics and gynecology,
R G Dickinson, and C H Lawyer, and S N Kaufman, and R K Lynn, and N Gerber, and M J Novy, and M J Cook
February 1995, Cancer research,
R G Dickinson, and C H Lawyer, and S N Kaufman, and R K Lynn, and N Gerber, and M J Novy, and M J Cook
January 2016, PloS one,
Copied contents to your clipboard!